Published in the American Journal of Public Health, this article written by staff at the Center for Public Health Law Research identifies and categorizes US state legislation introduced between January 1, 2021, and May 20, 2022 that addresses emergency health authority. The COVID-19 pandemic called for quick, decisive action to limit infections, and when the next outbreak hits, new laws limiting health authority may make such action even more difficult.
State laws setting the scope and limits of emergency authority are crucial to an effective public health response. This suite of legal data captures details of legislation that addresses emergency health authority introduced between January 1, 2021, and May 20, 2022, in all 50 US states and the District of Columbia.
This dataset is cross-sectional and displays key features of state Medicaid Waivers addressing COVID-19 across all 50 states and the District of Columbia approved as of July 1, 2021.
This dataset, published on PDAPS.org, is cross-sectional and displays key features of state laws increasing access to buprenorphine and methadone during COVID-19 across all 50 states and the District of Columbia approved as of June 1, 2021.
This dataset, published on PDAPS.org, is cross-sectional and displays key features of mitigation laws at state correctional facilities relating to MOUD treatment across all 50 states and the District of Columbia in effect as of September 1, 2021.
This longitudinal sentinel surveillance dataset provides an overview of laws that limit the authority of a governor, state health agency, or state health official, regarding public health emergency orders. The dataset covers all 50 U.S. states and the District of Columbia and includes laws that were enacted since January 1, 2021, and were effective on or before May 20, 2022.
This research, produced by the International and Comparative Law Research Center with expertise from staff from the Center for Public Health Law Research, examines the legal framework applicable to emergencies in general and the current pandemic at the international, regional (EAEU, EU), and national levels (China, France, Germany, Italy, the Russian Federation and its subjects, Spain, Sweden, the United Kingdom, the United States). It includes both the preexisting regulation and its evolution caused by the COVID-19 pandemic.
This international legal research report, produced by the International and Comparative Law Research Center and including experts from the Center for Public Health Law Research, seeks to document effective mechanisms for legal regulation of the development and production of vaccines and the vaccination process at the universal, regional, and national levels.
This essay in The Regulatory Review examines the legacy of the US Supreme Court case Jacobson v. Massachusetts in the context of the COVID-19 pandemic. Author Scott Burris contends that the vision set by Jacobson — one of coexistence and cooperation in a democratic commonwealth — is in jeopardy as courts in recent COVID-19 constitutional cases have unveiled a new view based less on the social contract than on a strong form of libertarianism.
